Skip to main content

Table 1

From: Virologic failure and metabolic syndrome in patients with HIV infection

 

SM+

SM-

p

Systolic BP, mmHg

129.84 ± 14.43

117.72 ± 14.67

< 0.0001

Diastolic BP, mmHg

86.88 ± 11.01

76.43 ± 12.42

< 0.0001

Glucose, mg/dL

107.73 ± 34.57

91.74 ± 13.84

< 0.0001

HDL, mg/dL

35.85 ± 8.63

48.84 ± 16.08

< 0.0001

Triglycerides, mg/dL

300.91 ± 206.15

179.15 ± 159.54

< 0.0001

Apo B, mg/dL

111.51 ± 29.64

100.57 ± 31.22

< 0.0001

TCol/HDL

5.58 ± 1.63

4.21 ± 1.46

< 0.0001

HOMA > 3.8, n (%)

210 (65.02)

354 (35.36)

< 0.0001

HOMA, median (IQR)

5.14 (3.00; 8.15)

2.95 (1.93; 4.57)

< 0.0001

HIV duration, months

169.33 ± 62.15

172.35 ± 64.46

0.46

Log10 VL

2.17 ± 0.94

2.02 ± 0.79

0.0048

CD4 nadir, median (IQR)

150 (50; 250)

146 (60; 238)

0.86

CD4 current, median (IQR)

500 (342; 701)

502 (357; 681)

0.99

BMI

25.17 ± 4.40

22.80 ± 3.38

< 0.0001

Waist, cm

91.04 ± 11.27

83.71 ± 9.41

< 0.0001

PI current

199 (61.61)

529 (52.85)

0.006

NRTI current

321 (99.38)

998 (98.70)

0.31

NNRTI current

90 (27.86)

381 (38.06)

0.001

PI exposure, months

51.37 ± 47.95

49.05 ± 43.57

0.41

NRTI exposure, months

104.08 ± 58.67

108.46 ± 56.17

0.23

NNRTI exposure, months

26.15 ± 26.78

30.18 ± 30.94

0.0358

HCV

102 (31.58)

372 (37.16)

0.17

VAT/TAT

0.54 ± 0.17

0.48 ± 0.18

< 0.0001

%fat leg, median (IQR)

8.97 (5.89; 15.79)

9.67 (5.86; 15.88)

0.61

%fat leg/BMI, median (IQR)

0.36 (0.25; 0.61)

0.41 (0.26; 0.70)

0.0074

Trunk fat, g

7343.25 ± 3720.89

5943.93 ± 3219.04

< 0.0001

Total fat, g

12451.16 ± 7293.54

10200.50 ± 5768.74

< 0.0001

Total lean, g

53038.16 ± 9722.90

48689.95 ± 10030.84

< 0.0001